Researchers explore the links between non-dipper hypertension, obstructive sleep apnea (OSA), and Alzheimer’s disease (AD). They find that OSA may cause non-dipper hypertension, a condition that exacerbates AD symptoms, but also note that treating OSA can mitigate hypertension and potentially slow AD progression.
Stakeholders weigh in on potential reforms to FDA advisory committee process
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS